133 related articles for article (PubMed ID: 11376802)
1. Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region.
Ge XQ; Tanaka K; Mansyur A; Tazawa H; Iwato K; Kyo T; Dohy H; Kamada N
Cancer Genet Cytogenet; 2001 Apr; 126(2):102-10. PubMed ID: 11376802
[TBL] [Abstract][Full Text] [Related]
2. Different methylation patterns of the M-BCR gene in myeloblastic and lymphoblastic crisis of chronic myelocytic leukemia.
Ge X; Tanaka K; Kamada N
Chin Med J (Engl); 1996 Apr; 109(4):300-3. PubMed ID: 8758292
[TBL] [Abstract][Full Text] [Related]
3. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
[TBL] [Abstract][Full Text] [Related]
4. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
5. Methylation status of the major breakpoint cluster region in Philadelphia chromosome negative leukemias.
Litz CE; McClure JS; Coad JE; Goldfarb AN; Brunning RD
Leukemia; 1992 Jan; 6(1):35-41. PubMed ID: 1346543
[TBL] [Abstract][Full Text] [Related]
6. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
7. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML.
Mills KI; Sproul AM; Burnett AK
Leukemia; 1993 May; 7(5):707-11. PubMed ID: 7683349
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of the breakpoint sites within the M-BCR in 50 patients from Argentina with chronic myeloid leukemia.
Giere IA; Larripa IB
Leuk Lymphoma; 1996 Aug; 22(5-6):519-22. PubMed ID: 8882967
[TBL] [Abstract][Full Text] [Related]
10. p190 BCR-ABL rearrangement in chronic myeloid leukemia and acute lymphoblastic leukemia.
Lemes A; Gómez Casares MT; de la Iglesia S; Matutes E; Molero MT
Cancer Genet Cytogenet; 1999 Aug; 113(1):100-2. PubMed ID: 10459357
[TBL] [Abstract][Full Text] [Related]
11. Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase.
Morris SW; Daniel L; Ahmed CM; Elias A; Lebowitz P
Blood; 1990 May; 75(10):2035-41. PubMed ID: 2337672
[TBL] [Abstract][Full Text] [Related]
12. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
13. [Rearrangement and expression of bcr-abl genes in CML and ALL].
Kunieda Y; Okabe M
Rinsho Ketsueki; 1991 Jun; 32(6):623-8. PubMed ID: 1890738
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the site of M-bcr breakpoint with chronic phase duration, blastic crisis lineage and thrombocytosis in Ph1-positive chronic myelogenous leukemia.
Viniou NA; Matzourani M; Yataganas X; Meletis J; Pangalis G; Loukopoulos D
Leuk Lymphoma; 1995 Jul; 18(3-4):335-9. PubMed ID: 8535202
[TBL] [Abstract][Full Text] [Related]
15. [Ph1-positive leukemia: cytogenetic outline and prognosis].
Misawa S
Nihon Rinsho; 1992 Jun; 50(6):1274-80. PubMed ID: 1518145
[TBL] [Abstract][Full Text] [Related]
16. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
17. Identical utilization of T-cell receptor gene regions in B-lymphoid blast crisis of chronic myeloid leukemia and B-precursor acute lymphoblastic leukemia.
di Celle PF; Carbone A; Lo Coco F; Guerrasio A; Diverio D; Rosso C; Lopez M; Saglio G; Foà R
Leukemia; 1991 May; 5(5):366-72. PubMed ID: 1827853
[TBL] [Abstract][Full Text] [Related]
18. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
Kolenova A; Maloney KW; Hunger SP
J Pediatr Hematol Oncol; 2016 Aug; 38(6):e193-5. PubMed ID: 27164534
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of a CML patient with a long duration of chronic phase before and after lymphoid blast crisis.
Price CM; Foadi MD; Morgan GJ; Wiedemann LM
Leukemia; 1990 Jun; 4(6):455-7. PubMed ID: 2359347
[TBL] [Abstract][Full Text] [Related]
20. Presence of cell lineage-specific hypomethylated sites in the major breakpoint cluster region.
Litz CE; Goldfarb AN; Strickler JG; Brunning RD
Cancer Res; 1990 Aug; 50(16):4984-90. PubMed ID: 2379163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
